3) 石川俊次, 野口律奈, 食事飽和脂肪酸・コレステロールと動脈硬化-最近の考え方. オレオサイエンス, 12 : 99-105 (2012)
17) USDA, Scientific Report of the 2015 Dietary Guidelines Advisory Committee, Feburary 2015
21) 厚生労働省「日本人の食事摂取基準」策定委員会報告書, 日本人の食事摂取基準, 2015年版, 第一出版 (2014)
22) Hooper L, Summerbell CD, Thompson R et al., Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev., 2012 May 16; 5 : CD002137. doi : 10.1002/14651858. CD002137. pub3.
24) Toda N, Maruyama C, Koba S et al., Japanese dietary lifestyle and cardiovascular disease. J. Atheroscler. Thromb., 18 : 723-734 (2011)
30) Hays KV, Pronczuk A, Replacing trans fat : the augment for palm oil with a cautionary note on interesterification. J. Am. Coll. Nutr., 29 : 253S-284S (2010)
34) Kris-Etherton PM, Griel AE, Psota TL et al., Dietary stearic acid and risk of cardiovascular disease : intake, sources, digestion, and absorption. Lipids, 40 : 1193-1200 (2005)
37) Lacroix S, Des Rosiers C, Gayda M et al., Impact of a single mixed Mediterranean-type meal relative to a high-fat meal on metabolic markers and postprandial endothelial function. Can. J. Cardiol., 27 : S174-S175 (2012)
39) 佐藤清隆, 油の美味しさと飽和脂肪酸. オレオサイエンス, 12 : 424 (2012)
43) Kuklina EV, Carroll MD, Shaw KM et al., Trends in high LDL cholesterol, cholesterol-lowering medication use, and dietary saturated-fat intake : United States, 1976-2010. National Center for Health Statistics (NCHS) Data Brief No.117 : 1-8 March 2013
47) O'Sullivan TA, Hafekost K, Mitrou F et al., Food sources of saturated fat and the association with mortality : a meta-analysis. Am. J. Public Health, 103 : e31-e42 (2013)
49) Waterman E, Lockwood B, Active components and clinical applications of olive oil. Altern. Med. Rev., 12 : 331-342 (2007)
51) Karkoula E, Melliou E, Magiatis P, A new method for the estimation of olive oil healthfulness. Inform, 24 : 266-270 (2013)
52) Estruch R, Ros E, Salas-Salvado J et al., Primary prevention of cardiovascular disease with a Mediterranean diet. N. Engl. J. Med., 368 : 1279-1290 (2013)
54) Brown ML, Shelness GS, Rudel LL, Monounsaturated fatty acids and atherosclerosis : opposing view from epidemiology and experimental animal models. Curr. Atheroscler. Rep., 9 : 494-500 (2007)
55) Jakobsen MU, O'Reilly EJ, Heitmann BL et al., Major types of dietary fat and risk of coronary heart disease : a pooled analysis of 11 cohort studies. Am. J. Clin. Nutr., 89 : 1425-1432 (2009)
57) Rudel LL, MUFA-Mediterraneans love olive oil, but is it our friend or foe? J. Clin. Lipidol., 6 : 221-223 (2012)
61) Schwingshakl L, Strasser B, Hoffmann G, Effects of monounsaturated fatty acids on cardiovascular risk factors : a systematic review and meta-analysis. Ann. Nutr. Metab., 59 : 176-186 (2011)
65) Kurotani K, Sato M, Ejima Y et al., High levels of stearic acid, palmitoleic acid, and dihomo-γ-linolenic acid and low levels of linoleic acid in serum cholesterol esters are associated with high insulin resistance. Nutr. Res., 32 : 669-675 (2012)
68) 農林水産省食品製造卸売課, 我が国の油脂事情 (2012)
69) Liu L, Iassonova D, High-oleic canola oils and their food applications. Inform, 23 : 491-495 (2012)
70) Slater AM, Dietary fatty acids and cardiovascular disease. Animal, 7 (Suppl. s1) :163-171 (2013)
72) Kris-Etherton P, Fleming J, Harris WS et al., The debate about n-6 polyunsaturated fatty acid recommendations for cardiovascular health. J. Am. Diet. Assoc., 110 : 201-204 (2010)
79) Gueraud F, Atalay M, Bresgen N et al., Chemistry and biochemistry of lipid peroxydation products. Free Radic. Res., 44 : 1098-1124 (2010)
89) Sasaki J, Yokoyama M, Matsuzaki M et al., Relationship between coronary artery disease and non-HDL-C, and effect of highly purified EPA on the risk of coronary artery disease in hypercholesterolemic patients treated with statins. sub-analysis of the Japan EPA Lipid Intervention Study (JELIS). J. Atheroscl. Thromb., 19 : 194-204 (2011)
91) Delgado-Lista J, Perez-Martinez P, Lopez-Miranda J et al., Long chain omega-3 fatty acids and cardiovascular disease : a systematic review. Brit. J. Nutr., 107 : S201-S213 (2012)
92) Kwak SM, Myung SK, Lee YJ et al., Efficacy of omega-3 fatty acid supplements (eicosapetaenoic acid and dososahexaenoic acid) in the secondary prevention of cardiovascular disease. Arch. Intern. Med., 172 : 686-694 (2012)
97) Harris WS, The omega-6/omega-3 ratio and cardiovascular disease risk : uses and abuses. Curr. Atheroscler. Rep., 8 : 456-459 ( 2006)
103) Brenna JT, Salem N Jr., Sinclair AJ et al., α-Linolenic acid supplementation and conversion to n-3 long-chain polyunsaturated fatty acids in humans. Prostagl. Leukot. Essent. Fatty Acids, 80 : 85-91 (2009)
106) 西川正純, 脂肪酸 (α-リノレン酸, EPA・DHA, アラキドン酸). 食品機能性成分の吸収・代謝機構 (宮澤陽夫監修), p.159-166, シーエムシー出版 (2013)
113) World Cancer Research Fund/American Institute for Cancer Research, Food, Nutrition, Physical Activity, and the Prevention of Cancer : a Global Perspective. American Institute for Cancer Research (2007)
119) 榊原学, アラキドン酸を中心とする高度不飽和脂肪酸が加齢脳に及ぼす効果とそのメカニズム. オレオサイエンス, 12 : 273-282 (2012)
120) 山口進, アラキドン酸による食品の美味しさ向上効果. オレオサイエンス, 12 : 283-288 (2012)
121) Mozaffarian D, Lemaitre RN, King IB et al., Plasma phospholipid long-chain ω-3 fatty acids and total and cause-specific mortality in older adults : a cohort study. Ann. Intern. Med., 158 : 515-525 (2013)
122) 大塚礼, 加藤友紀, 今井具子他, 地域在住中高年男女における性・年齢群別の血清脂肪酸構成比率. 日本栄養・食糧学会誌, 66 : 147-153 (2013)
125) 岡島伸浩, 魚油. 油脂の特性と応用 (戸谷洋一郎監修), p.373-387, 幸書房 (2012)
130) Kohler A, Sarkkinen E, Tapola N et al., Bioavailability of fatty acids from krill oil, krill meal and fish oil in healthy subjects-a randomized, single-dose, cross-over trial. Lipids Health Dis., 14 : 19 (2015)
133) Nys M, Debruyne I, Global omega-3 summit 2013 highlights. Inform, 24 (9) : S4-S7 (2013)
135) Guesnet P, Lallemand SM, Alessandri JM et al., α-Linolenate reduces the dietary requirement for linoleate in the growing rat. Prostagl. Leukot. Essent. Fatty Acids, 85 : 353-360 (2011)
137) Farvid MS, Ding M, Pan A et al., Dietary linoleic acid and risk of coronary heart disease : a systematic review and meta-analysis of prospective cohort studies. Circulation, 130 : 1568-1578 (2014)
143) 菅野道廣監修, 特集 : わが国におけるトランス脂肪酸問題を考える. 明日の食品産業, 通巻425号 : 1-45 (2012)
147) 渡邉敬浩, 石川智子, 松田りえ子, GC-FIDを用いたトランス脂肪酸分析法の性能評価手法および性能基準値の検討. 食衛誌, 54 : 31-48 (2013)
148) 塩田誠, キャピラリーガスクロマトグラフ法によるトランス脂肪酸定量技術. 調理科学会誌, 48 : 229-239 (2015)
149) Zook PL, Katan MB, Trans fatty acids, lipoproteins, and coronary risk. Can. J. Physiol. Pharmacol., 75 : 211-216 (1997)
168) Gayet-Boyer C, Tenenhaus-Aziza F, Prunet C et al., Is there linear relationship between the dose of ruminant trans-fatty acids and cardiovascular risk markers in healthy subjects : results from a systematic review and meta-regression of randomised clinical trials. Brit. J. Nutr. 112 : 1914-1922 (2014)
178) Rahkovsky I, Martinez S, Kuchler F, New food choices free of trans fats better align U.S. diets with health recommendations. USDA Economic Information Bulletin No. 95, p.1-33 (2012)
179) 川端輝江, 兵庫弘夏, 荻原千絵他, 食事の実測による若年女性のトランス脂肪酸摂取量. 日本栄養・食糧学会誌, 61 : 161-168 (2008)
182) Colon-Ramos U, Monge-Rohas R, Campos H, Impact of WHO recommendations to eliminate industrial trans-fatty acids from the food supply in Latin America and Caribbean. Health Policy Plan., 2013 Oct 21, doi : 10.1093/heapol/czt034
183) Vannce G, Rasmussen H, Position of the academy of nutrition and dietetics : dietary fatty acids for healthy adults. J. Acad. Nutr. Diet., 114 : 136-153 (2014)
184) 白砂尋士, トランス脂肪酸の低減化に向けて. 日本調理科学会誌, 45 : 223-227 (2012)
189) Otite FO, Jacobson MF, Dahmubed A et al., Trends in trans fatty acids reformulations of US supermarket and brand-name foods from 2007 through 2011. Prev. Chronic Dis., 10 :
http://dx.doi.org/20.5888/pcd10.120198
193) 菅野道廣 : トランス脂肪酸の安全性. New Diet Therapy, 28 : 79-82 (2013)
194) Federal Register, 64 (No.221) : 64627-62825 (1999) (p.62760参照)
196) 丸山武紀, トランス脂肪酸と健康. オレオサイエンス, 13 : 259-266 (2013)
199) Mu H, Hoy C-E, Intestinal absorption of specific structured triacylglycerols. J. Lipid Res., 42 : 792-798 (2001)
202) Wymelbeke VV, Himaya A, Louis-Sylvestre J et al., Influence of medium-chain and long-chain triacylglycerols on control of food intake in men. Am. J. Clin. Nutr., 68 : 226-234 (1998)
203) Chiasson J-L, Aris-Jilwan N, Belanger R et al., Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. Can. Med. Assoc. J., 168 : 859-866 (2001)
205) 青山敏明, 中鎖脂肪酸の栄養学的研究-最近の研究を中心に-. オレオサイエンス, 3 : 403-410 (2003)
207) Timm-Heinrich M, Xu X, Nielsen NS et al., Oxidative stability of structured lipids produced from sunaower oil and caprylic aicd. Eur. J. Lipid Sci. Technol., 105 : 436-448 (2003)
211) Kasai M, Nosaka N, Maki H et al., Effect of dietary medium- and long-chain triacylglycerols (MLCT) on accumulation of body fat in healthy humans. Asia Pacific J. Clin. Nutr., 12 : 151-160 (2003)
214) Liu Y, Wan J, Zhang R et al., A good response to oil with medium- and long-chain fatty acids in body fat and blood lipid profiles of male hypertriglyceridemic subjects. Asia Pacific J. Clin. Nutr., 18 : 351-358 (2009)
221) 野坂直久, 足立香代子, 川島由紀子他, タンパク・エネルギー低栄養 (PEM) のリスクを保有する高齢者における中鎖脂肪酸摂取が血清アルブミン値に及ぼす影響. 日本臨床栄養学会雑誌, 32 : 52-61 (2010)
227) Gonzalez-Lima F, Barksdale BR, Rohas JC, Mitochondrial respiration as a target for neuroprotection and cognitive enhancement. Biochem. Pharamacol., 88 : 584-593 (2014)
230) Kathleen PA, Williamson A, Yu N et al., Medium-chain fatty acids improve cognitive function in intensively treated type 1 diabetic patients and support in vitro synaptic transmission during acute hypoglycemia. Diabetes, 58 : 1237-1244 (2009)
232) 大塚礼, 加藤友紀, 西田裕紀子他, 地域在住高齢者における短鎖および中鎖脂肪酸摂取が8年間の認知機能得点低下に及ぼす影響. 日本栄養・食糧学会誌, 68 : 101-111 (2015)
234) Rhinn H, Fujita R, Qiang L et al., Integrative genomics identifies APOE ε4 effectors in Alzheimer's disease. Nature, 500 (7460) : 45-50 (2013)